Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$751M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$692M |
| 3 |
Palantir
PLTR
|
+$434M |
| 4 |
Union Pacific
UNP
|
+$377M |
| 5 |
AbbVie
ABBV
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.74B |
| 2 |
Meta Platforms (Facebook)
META
|
+$602M |
| 3 |
Bank of America
BAC
|
+$600M |
| 4 |
Wells Fargo
WFC
|
+$568M |
| 5 |
Broadcom
AVGO
|
+$538M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.73% |
| 2 | Financials | 7.42% |
| 3 | Healthcare | 6.65% |
| 4 | Industrials | 6.3% |
| 5 | Consumer Discretionary | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5176
BlackRock Municipal 2030 Target Term Trust
BTT
$1.43B
| $235K | ﹤0.01% |
+10,742
| New | +$228K |
|
|
IMSRW
5177
CALL
Terrestrial Energy Warrant
IMSRW
$22.2M
| $235K | ﹤0.01% |
100,000
| – | – |
|
|
FSP
5178
Franklin Street Properties
FSP
$50.1M
| $235K | ﹤0.01% |
+143,138
| New | +$239K |
|
5179
Sanara MedTech
SMTI
$244M
| $235K | ﹤0.01% |
+8,266
| New | +$248K |
|
5180
Pharvaris
PHVS
$2.35B
| $234K | ﹤0.01% |
+13,285
| New | +$214K |
|
5181
SEALSQ Corp
LAES
$521M
| $234K | ﹤0.01% |
57,976
-191,544
| -77% | -$588K |
|
5182
TAT Technologies
TATT
$547M
| $233K | ﹤0.01% |
7,628
-2,923
| -28% | -$84.1K |
|
5183
PubMatic
PUBM
$605M
| $233K | ﹤0.01% |
18,721
-104,003
| -85% | -$1.1M |
|
5184
Nuvectis Pharma
NVCT
$625M
| $233K | ﹤0.01% |
31,167
-89,934
| -74% | -$816K |
|
5185
CALL
Abercrombie & Fitch
ANF
$4.58B
| $232K | ﹤0.01% |
2,800
-1,000
| -26% | -$75.9K |
|
5186
Stoke Therapeutics
STOK
$1.83B
| $231K | ﹤0.01% |
20,396
+776
| +4% | +$7.37K |
|
|
KEEL
5187
Keel Infrastructure Corp
KEEL
$2.25B
| $231K | ﹤0.01% |
275,244
-1,575,386
| -85% | -$1.46M |
|
|
IPCXR
5188
Inflection Point Acquisition Corp III Rights
IPCXR
| $231K | ﹤0.01% |
+579,862
| New | +$206K |
|
5189
CALL
Tango Therapeutics
TNGX
$4.34B
| $230K | ﹤0.01% |
+45,000
| New | +$111K |
|
5190
Pricesmart
PSMT
$5.9B
| $230K | ﹤0.01% |
2,189
-30,843
| -93% | -$3.11M |
|
5191
Health Catalyst
HCAT
$158M
| $229K | ﹤0.01% |
60,826
-437,255
| -88% | -$1.72M |
|
5192
Crawford & Co Class B
CRD.B
$502M
| $229K | ﹤0.01% |
21,951
+4,553
| +26% | +$46.7K |
|
|
TEAF
5193
DELISTED
Ecofin Sustainable & Social Impact Term Fund
TEAF
| $229K | ﹤0.01% |
18,665
| – | – |
|
5194
Capital City Bank Group
CCBG
$904M
| $228K | ﹤0.01% |
+5,805
| New | +$214K |
|
5195
PUT
Global E Online
GLBE
$6.53B
| $228K | ﹤0.01% |
+6,800
| New | +$229K |
|
|
CANG
5196
Cango Inc
CANG
$69.7M
| $228K | ﹤0.01% |
4,699
-6,543
| -58% | -$283K |
|
5197
CALL
Otis Worldwide
OTIS
$28B
| $228K | ﹤0.01% |
2,300
-18,200
| -89% | -$1.76M |
|
5198
PUT
Charles River Laboratories
CRL
$11.6B
| $228K | ﹤0.01% |
+1,500
| New | +$200K |
|
5199
BlackRock MuniHoldings Fund
MHD
$600M
| $227K | ﹤0.01% |
+20,271
| New | +$228K |
|
5200
Sight Sciences
SGHT
$288M
| $225K | ﹤0.01% |
54,581
-629,352
| -92% | -$2.1M |
|
Similar funds
Millennium Management's Q2 2025 Portfolio in Review
As of Q2 2025, Millennium Management held 6,516 positions worth $207B, up 10% from $188B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Millennium Management's Q2 2025 filing shows 738 new, 2,295 increased, 2,418 reduced and 712 closed positions. Its largest new stake was Bank of America Series L: 164,000 shares worth $197K. The largest sale was iShares Core S&P 500 ETF, an estimated $1.74B.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 7.8% a quarter earlier, followed by Financials and Healthcare.
- Millennium Management's largest Q2 2025 buy was Bank of America Series L: 164,000 shares worth $197K.
- Millennium Management added most to Applovin in Q2 2025, an estimated $751M increase.
- Millennium Management's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.74B.
- Millennium Management fully exited Discover Financial Services in Q2 2025, selling an estimated $282M.
- Millennium Management's ten largest holdings make up 16% of its $207B portfolio in Q2 2025.
- Millennium Management opened 738 new positions and closed 712 in Q2 2025.
- Millennium Management's portfolio value rose 10% quarter-over-quarter to $207B.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.